Literature DB >> 16405615

A case of Darier's disease successfully treated with topical tacrolimus.

P Rubegni1, S Poggiali, P Sbano, M Risulo, M Fimiani.   

Abstract

Tacrolimus is a macrolide that inhibits T-cell activation. The most extensive experience with topical tacrolimus has been in treating atopic dermatitis but it has been used in various skin diseases, including Hailey-Hailey disease, with encouraging results. We report a case of extensive Darier's disease successfully treated with topical tacrolimus, after suspension of oral isotretrinoin due to major depression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16405615     DOI: 10.1111/j.1468-3083.2005.01352.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  5 in total

1.  [Segmental Darier disease : treatment with pulsed dye laser].

Authors:  L Schmitt; S Roos; C Raulin; S Karsai
Journal:  Hautarzt       Date:  2009-12       Impact factor: 0.751

Review 2.  Management of Darier disease: A review of the literature and update.

Authors:  Roger N Haber; Nicole G Dib
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jan-Feb       Impact factor: 2.545

3.  Long-term improvement of recalcitrant Darier disease with photon and electron beam radiation therapy.

Authors:  Nicole Leung; Adela R Cardones; Nicole Larrier
Journal:  JAAD Case Rep       Date:  2018-11-14

4.  Botulinum toxin injections as an effective treatment for patients with intertriginous Hailey-Hailey or Darier disease: an open-label 6-month pilot interventional study.

Authors:  Isabelle Dreyfus; Aude Maza; Lauriane Rodriguez; Margot Merlos; Hélène Texier; Vanessa Rousseau; Agnès Sommet; Juliette Mazereeuw-Hautier
Journal:  Orphanet J Rare Dis       Date:  2021-02-18       Impact factor: 4.123

Review 5.  Therapeutic Options for the Treatment of Darier's Disease: A Comprehensive Review of the Literature.

Authors:  Nardin Hanna; Megan Lam; Patrick Fleming; Charles W Lynde
Journal:  J Cutan Med Surg       Date:  2021-11-28       Impact factor: 2.854

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.